Bluestar Adisseo Company (SHA:600299)

Market Cap	42.50B +47.3%
Revenue (ttm)	17.23B +10.9%
Net Income	1.15B -4.1%
EPS	0.43 -4.3%
Shares Out	3.08B
PE Ratio	32.12
Forward PE	30.67
Dividend	0.15 (1.07%)
Ex-Dividend Date	Feb 27, 2026

Volume	21,778,025
Average Volume	35,881,426
Open	14.01
Previous Close	14.08
Day's Range	13.64 - 14.06
52-Week Range	8.66 - 16.48
Beta	0.43
RSI	53.50
Earnings Date	Apr 30, 2026

About Bluestar Adisseo Company

Bluestar Adisseo Company, together with its subsidiaries, engages in the research, development, production, and sale of poultry, ruminant, swine, and aquaculture nutrition additives. The company also offers mycotoxin management and palatability comprising, Unike Plus, Unike, Oxy-Nil, Mold-Nil, Salmo-Nil, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, Delistart, Pepsea, Nutri-Bind Aqua, and Oxy-Nil Aqua Zero; enzymes and emulsifiers, including Rhodimet AT88 and Rhodimet; antioxidants and health by nutrition products, comprising Rhodimet AT...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1939
• Employees: 3,295
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600299

Financial Performance

In 2025, Bluestar Adisseo Company's revenue was 17.23 billion, an increase of 10.92% compared to the previous year's 15.53 billion. Earnings were 1.15 billion, a decrease of -4.13%.